2019
DOI: 10.1590/1678-9199-jvatitd-2019-0013
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Zika virus proteins at an atomic scale: how does structural biology help us to understand and develop vaccines and drugs against Zika virus infection?

Abstract: In Brazil and in other tropical areas Zika virus infection was directly associated with clinical complications as microcephaly in newborn children whose mothers were infected during pregnancy and the Guillain-Barré syndrome in adults. Recently, research has been focused on developing new vaccines and drug candidates against Zika virus infection since none of those are available. In order to contribute to vaccine and drug development efforts, it becomes important the understanding of the molecular basis of the … Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
30
5
4
1

Citation Types

0
26
0
0

Year Published

Range
2020
2020
2026
2026

Publication Types

Select...
31
2
2
1

Relationship

0
36

Authors

Journals

citations

Cited by 35 publications

(26 citation statements)
references

References 92 publications

0
26
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…It has also been shown that several other ligands associated with the RdRp proteins have at least one adenosyl group, [69] which is similar to the chemical structure of caffeine; therefore, it could be speculated that caffeine acts by inhibiting these particular proteins, leaving the virus without replicative capacity after entering the host cell. Another study showed that caffeine inhibits RNA-dependent DNA polymerase (RdDp) activity of the Rauscher leukemia virus when endogenous viral RNA and poly(rA) • (dT) 12-18 or purified RdDP from avian myeloblastosis virus were used as templates.…”
Section: Discussion
mentioning
confidence: 95%